Job offersmore »

Tweeting Growers

Top 5 - yesterday

Top 5 - last week

Top 5 - last month

Exchange ratesmore »

KeyGene bolsters patents and licensing program

KeyGene has further strengthened its Next Generation Sequencing (NGS) patent estate by recent grants of patents in the United States, China, Hong Kong and India. Furthermore, KeyGene announces expansion of its out-licensing program. The company aims to enable service providers, research- and diagnostic product manufacturers as well as academic organizations globally to use and offer its patented technologies. Recently issued patents protecting methods for NGS-based variant detection include US 9,702,004, US 9,777,324, and US 9,745,627, ZL201410177894.1 (China and Hong-Kong) and 289590 and 287606 (India).

To serve its customers in crop improvement KeyGene has developed a number of highly sensitive and cost-effective NGS-based workflows. These methods enable discovery and detection of genetic variation, either naturally occurring or introduced via random mutagenesis. Methods included are Sequence-Based Genotyping, KeyPoint mutation screening and KeyGene SNPSelect. Beyond application in crops, these molecular indexing, barcoded amplicon and (exome) capturing approaches are powerful in today’s life sciences research and diagnostics. Application areas encompass farm animal breeding and human hereditary and somatic mutation detection including liquid biopsies.

KeyGene offers its patented NGS applications to customers and licensees and concluded more than twenty license agreements. To continue providing broad access to these powerful methods, KeyGene is committed to license interested parties in all fields of life sciences.

Arjen van Tunen, CEO of KeyGene, states: “NGS methods have revolutionized the way genetic analysis and molecular diagnostics are conducted today. They provide unparalleled sensitivity, speed and accuracy. Conventional detection platforms have been replaced by direct read-out of genetic variants at the sequence level, even when extremely rare. The revolutionary impact of NGS on research and diagnostics has now become truly visible and provides new opportunities for crop variety development to produce more food and feed and in the medical field to diagnose, prevent and cure diseases. We are committed to advance crop improvement using NGS and are also keen to see these methods being adopted in other fields of use.”

For more information:
KeyGene Netherlands
Agro Business Park 90
6708 PW Wageningen
The Netherlands

P.O. Box 216
6700 AE Wageningen
The Netherlands
T +31 (0)317 466 866
F +31 (0)317 424 939

Publication date: 1/12/2018



Other news in this sector:

1/19/2018 US (WI): Seed saver preserves rare tomato varieties
1/19/2018 Syngenta and Kumato team up to offer new pepper varieties
1/18/2018 Prince de Bretagne launches new range of tomatoes
1/18/2018 Private equity investor to fund seed growers in Bhutan
1/16/2018 Syngenta and NRGene expand collaboration
1/16/2018 US: Broad files update to CRISPR-Cas9 portfolio
1/16/2018 KeyGene licenses sequence-based genotyping patents
1/15/2018 "Plant breeding is key to sustainable farming"
1/15/2018 UK: Summer fruiting raspberry variety trial
1/12/2018 NL: Windows shattered at De Ruiter Experience Center
1/11/2018 US (MI): "Farmers market growers love AAS winners"
1/11/2018 India: Tomato growers root for high-yield varieties
1/10/2018 "Encouraged by Agriculture and Rural Prosperity task force report"
1/9/2018 US: Intellectual property rights for new plant varieties have expanded
1/8/2018 India: Scientist produces ‘hottest hybrid chilli’
1/8/2018 PhD assessing the traditional African vegetable, Cleome gynandra
1/4/2018 Increasing the income of 12,500 seed growers all over in Indonesia
1/4/2018 Shanty tomato advances Ethiopian agriculture
1/3/2018 Space age plant breeding lights the way for future crops
1/3/2018 "World’s smallest and sweetest tomatoes" coming to Israel